Life Science Products Market Report 2024 (Global Edition)

Global Life Science Products Market Report 2024 Market Size Split by Product Type (Recombinant Proteins, Cell Lines, Antibodies, Others), by Application (Drug Discovery & Development, Basic Research, ...

Life Science Products Market Report Description

We have various report editions of Life Science Products Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Life science products Market

The competitive landscape of the life science products market is characterized by intense rivalry among industry players striving for market share. Key factors driving competition include innovation, product quality, pricing strategies, and distribution networks. Companies engage in continuous research and development to maintain competitiveness and meet evolving customer demands.

In December 2023, InvAscent, via its India Life Sciences Fund IV (ILSF IV), injects INR 1,100 Mn to secure a minority stake in Fleming Laboratories, a prominent active pharmaceutical ingredient (API) firm based in India. The investment aims to fuel Fleming's expansion efforts, including capacity enhancement and the development and introduction of new molecules. 

(Source: https://www.invascent.com/news-press/)

Top Companies Market Share in Life Science Products Industry: (In no particular order of Rank)

• Boehringer Ingelheim
• MedAvante
• Keste
• Cybage
• ICON
• Knowledgent
• ALTEN Colsoft Labs
• Epam
• Lonza Group
• BioForties
• Invasystems
• Accenture
• MethodSense
• BioRAFT
• Parexel International Corporation
• PRA International
• MedNet Solutions
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North America Life science products Market share was 40% of the total market

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue due to its robust healthcare infrastructure, extensive R&D investments, and high adoption of advanced technologies. Additionally, favourable government policies, strong regulatory frameworks, and a large base of biopharmaceutical companies contribute to market growth. Moreover, increasing prevalence of chronic diseases and a growing aging population drive demand for life science products. Furthermore, strategic collaborations between industry players and academic institutions foster innovation, propelling sales.

Asia-Pacific is the fastest-growing region due to expanding healthcare expenditure, rising demand for personalized medicine, and increasing prevalence of chronic diseases. Furthermore, the region benefits from a large pool of skilled labour, driving research and development activities. Moreover, favourable government initiatives aimed at boosting the healthcare sector, coupled with growing investments in biotechnology and pharmaceuticals, contribute to market expansion. Additionally, the presence of untapped markets and a growing focus on preventive healthcare further drive sales in the region.A

The current report Scope analyzes Life Science Products Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Life Science Products

According to Cognitive Market Research, the global life science products market size was estimated at USD 3514.2 Million out of which North America held the major market of around 40% of the global revenue with a market size of USD 1405.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031. Sales of life science products are expected to increase in North America due to a strong emphasis on research and development, supported by significant investments in biotechnology and pharmaceutical sectors. Moreover, the presence of leading biopharmaceutical companies and academic institutions fosters innovation and collaboration, driving market growth. Additionally, favourable regulatory policies and a large base of affluent healthcare consumers contribute to market expansion. In this region, the drug discovery & development segment is poised to grow substantially, fuelled by advancements in technology and increasing demand for novel therapeutics to address complex diseases.

• According to Cognitive Market Research, The United States life science products market had a market share of USD 1109.08 million in 2024 and is projected to grow at a CAGR of 9.2% during the forecast period. Sales of life science products in the U.S. will increase due to robust R&D investment, a large biopharmaceutical sector, favourable regulatory environment, and growing demand for personalized medicine and advanced diagnostics.
• Canada life science products market had a market share of USD 168.68 million in 2024 and is projected to grow at a CAGR of 10.2% during the forecast period. Increased healthcare spending, rising prevalence of chronic diseases, strong academic research institutions, and government support for innovation drive sales growth of life science products in Canada.
• Mexico life science products market had a market share of USD 127.92 million in 2024 and is projected to grow at a CAGR of 9.9% during the forecast period

Europe Life Science Products

According to Cognitive Market Research, with a market value of USD 3514.2 million in 2024 and projected to expand at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2031. Europe accounted for a share of around 30% of the global market size of USD 1054.26 million. Europe anticipates a surge in sales of life science products driven by growing investments in healthcare infrastructure and research initiatives. The region's strong regulatory framework and emphasis on quality assurance ensure high standards for life science products, bolstering consumer confidence and market growth. Furthermore, strategic partnerships between industry and academia promote innovation and product development. Additionally, increasing adoption of personalized medicine and advancements in molecular diagnostics contribute to market expansion. Within Europe, the biopharmaceutical production segment is expected to flourish, fuelled by the region's expertise in bio manufacturing and biosimilar development.

• The United Kingdom life science products market had a market share of USD 177.12 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period. The UK's sales of life science products will rise due to a strong pharmaceutical industry, world-class research institutions, government investment in healthcare innovation, and growing demand for precision medicine solutions.
• France life science products market had a market share of USD 96.99 million in 2024 and is projected to grow at a CAGR of 8.9% during the forecast period.
• Germany life science products market had a market share of USD 208.74 million in 2024 and is projected to grow at a CAGR of 9.9% during the forecast period. Germany anticipates sales growth in life science products driven by a strong biotechnology sector, emphasis on healthcare innovation, strategic partnerships between academia and industry, and growing demand for biopharmaceuticals and medical devices.
• Italy life science products market had a market share of USD 90.67 million in 2024 and is projected to grow at a CAGR of 9.1% during the forecast period.
• Russia life science products market had a market share of USD 163.41 million in 2024 and is projected to grow at a CAGR of 8.7% during the forecast period.
• Spain life science products market had a market share of USD 86.45 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period.
• Luxembourg life science products market had a market share of USD 32.68 million in 2024 and is projected to grow at a CAGR of 9.8% during the forecast period.
• Portugal life science products market had a market share of USD 22.14 million in 2024 and is projected to grow at a CAGR of 9.5% during the forecast period.
• Greece life science products market had a market share of USD 12.65 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period.
• Rest of Europe life science products market had a market share of USD 163.41 million in 2024 and is projected to grow at a CAGR of 8.4% during the forecast period.

Asia Pacific Life Science Products

According to Cognitive Market Research, the global life science products market size was estimated at USD 3514.2 Million out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 808.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.2% from 2024 to 2031. Asia Pacific is poised for significant growth in sales of life science products attributed to expanding healthcare infrastructure, rising healthcare expenditure, and increasing focus on precision medicine. The region's burgeoning biotechnology and pharmaceutical industries, coupled with government initiatives to promote innovation, create a conducive environment for market expansion. Furthermore, the adoption of digital health technologies and telemedicine solutions further accelerates market demand. In Asia Pacific, the diagnostic centres segment is expected to witness remarkable growth, driven by increasing demand for advanced diagnostic services and preventive healthcare measures.

• According to Cognitive Market Research, China's life science products market had a market share of USD 363.72 million in 2024 and is projected to grow at a CAGR of 12.7% during the forecast period. Sales of life science products in China will increase due to government support for biotechnology, expanding healthcare infrastructure, rising R&D investment, growing middle-class population, and increasing demand for personalized medicine solutions.
• Japan's life science products market had a market share of USD 111.54 million in 2024 and is projected to grow at a CAGR of 11.7% during the forecast period.
• India's life science products market had a market share of USD 96.99 million in 2024 and is projected to grow at a CAGR of 15.0% during the forecast period. India's sales of life science products will rise owing to a growing pharmaceutical market, increasing healthcare access, rising demand for generic drugs, government initiatives to promote innovation, and expanding biotechnology sector.
• South Korea's life science products market had a market share of USD 80.83 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period.
• Australia's life science products market had a market share of USD 42.03 million in 2024 and is projected to grow at a CAGR of 12.9% during the forecast period.
• South East Asia's life science products market had a market share of USD 55.77 million in 2024 and is projected to grow at a CAGR of 14.2% during the forecast period.
• Rest of Asia Pacific's life science products market had a market share of USD 57.39 million in 2024 and is projected to grow at a CAGR of 13.0% during the forecast period.

South America Life Science Products

According to Cognitive Market Research, the global life science products market size was estimated at USD 3514.2 Million out of which Latin America market of around 5% of the global revenue with a market size of USD 175.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.6% from 2024 to 2031. Latin America foresees a rise in sales of life science products propelled by increasing healthcare access and rising awareness about preventive healthcare measures. The region's growing population and expanding middle-class contribute to heightened demand for pharmaceuticals, diagnostics, and medical devices. Moreover, government initiatives aimed at improving healthcare infrastructure and addressing public health challenges drive market growth. Additionally, partnerships between global pharmaceutical companies and local manufacturers stimulate market expansion. Within Latin America, the antibodies segment is poised for significant growth, driven by increasing prevalence of infectious diseases and demand for immunotherapies.

• According to Cognitive Market Research, Brazil's life science products market had a market share of USD 75.20 million in 2024 and is projected to grow at a CAGR of 11.2% during the forecast period. Brazil anticipates sales growth in life science products driven by a large population, rising healthcare expenditure, growing prevalence of chronic diseases, government support for healthcare infrastructure, and expanding biopharmaceutical industry.
• Argentina's life science products market had a market share of USD 29.52 million in 2024 and is projected to grow at a CAGR of 11.5% during the forecast period. Sales of life science products in Argentina will increase due to expanding healthcare access, rising demand for pharmaceuticals, government initiatives to improve healthcare infrastructure, and growing investments in research and development.
• Colombia's life science products market had a market share of USD 15.64 million in 2024 and is projected to grow at a CAGR of 10.4% during the forecast period.
• Peru's life science products market had a market share of USD 14.41 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period.
• Chile's life science products market had a market share of USD 12.65 million in 2024 and is projected to grow at a CAGR of 10.9% during the forecast period.
• Rest of Latin America's life science products market had a market share of USD 28.29 million in 2024 and is projected to grow at a CAGR of 9.7% during the forecast period.

Middle East and Africa Life Science Products Market

According to Cognitive Market Research, the global life science products market size was estimated at USD 3514.2 Million out of which Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 70.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2031. Sales of life science products in the Middle East and Africa (MEA) region are poised for growth due to expanding healthcare infrastructure, rising investment in research and development, and increasing adoption of innovative medical technologies. Moreover, government initiatives to promote healthcare modernization and attract foreign investment contribute to market expansion. Additionally, partnerships between international life science companies and local stakeholders drive innovation and product availability. In MEA, the biopharmaceutical companies segment is expected to thrive, fuelled by a growing demand for specialty drugs and biologics.

 

• According to Cognitive Market Research, GCC Countries' life science products market had a market share of USD 30.08 million in 2024 and is projected to grow at a CAGR of 11.7% during the forecast period. Sales of life science products in GCC countries will rise due to increasing healthcare investments, government initiatives to promote healthcare tourism, growing demand for specialty drugs, and expanding biopharmaceutical industry.
• Egypt's life science products market had a market share of USD 7.38 million in 2024 and is projected to grow at a CAGR of 11.2% during the forecast period.
• South Africa's life science products market had a market share of USD 11.10 million in 2024 and is projected to grow at a CAGR of 11.9% during the forecast period. South Africa anticipates sales growth in life science products driven by a rising burden of disease, increasing healthcare expenditure, government support for healthcare innovation, and growing demand for diagnostic and therapeutic solutions.
• Turkey's life science products market had a market share of USD 6.04 million in 2024 and is projected to grow at a CAGR of 10.4% during the forecast period.
• Nigeria's life science products market had a market share of USD 7.38 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period.
• Rest of MEA's life science products market had a market share of USD 8.29 million in 2024 and is projected to grow at a CAGR of 9.9% during the forecast period.

Life Science Products Market Analysis

Life science products Market Product Type Segment Analysis

According to Cognitive Market Research, antibodies held the major market share over the forecast period due to their crucial role in diagnostics, therapeutics, and research. With increasing prevalence of chronic diseases and infectious illnesses, demand for antibody-based treatments and diagnostic assays rises. Moreover, advancements in monoclonal antibody technology enhance efficacy and specificity, further boosting sales. Additionally, rising investments in oncology research and personalized medicine fuel demand for targeted antibody therapies, sustaining market dominance.

Recombinant proteins are the fastest-growing category over the forecast period owing to expanding applications in therapeutics, diagnostics, and research. With growing demand for biologics and biosimilar, recombinant proteins find extensive use in drug development and production. Furthermore, advancements in protein engineering techniques and bioprocessing technologies enhance scalability and efficiency, driving market growth. Additionally, increasing investments in biopharmaceutical R&D and rising adoption of protein-based therapeutics further propel sales of recombinant proteins.

• Recombinant Proteins
• Cell Lines
• Antibodies
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Life Science Products Industry. Request a Free Sample PDF!

Life science products Market Application Segment Analysis

According to Cognitive Market Research, drug discovery & development hold a prominent market share due to increasing investments in pharmaceutical research and development. With a surge in demand for novel therapeutics to address unmet medical needs, the need for innovative drug discovery platforms and technologies rises. Moreover, advancements in genomics, proteomics, and high-throughput screening techniques accelerate drug discovery processes, driving sales. 

Biopharmaceutical production is the fastest-growing category over the forecast period owing to the expanding biologics market and rising demand for biopharmaceuticals. With a growing pipeline of biologic drugs and biosimilar, there is an increasing need for efficient and scalable manufacturing processes. Moreover, advancements in cell culture technology, protein purification techniques, and bioreactor systems enhance productivity and yield, driving sales. Additionally, the shift towards personalized medicine and targeted therapies further boosts demand for biopharmaceutical production, sustaining market growth.

• Drug Discovery & Development
• Basic Research
• Toxicity Screening
• Biopharmaceutical Production
• Drug Screening
• Tissue Engineering
• Forensic Testing

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Life Science Products End User Segment Analysis

According to Cognitive Market Research, biopharmaceutical companies hold a prominent market share due to their pivotal role in drug development and commercialization. With a robust pipeline of biologic drugs and biosimilar, there is a steady demand for life science products such as reagents, assays, and instrumentation. Moreover, strategic collaborations with academic institutions and contract research organizations drive innovation and expand product portfolios. Additionally, mergers and acquisitions enhance market presence and diversify revenue streams, sustaining sales for biopharmaceutical companies.

Diagnostic centres are the fastest-growing category over the forecast period owing to increasing demand for early disease detection and personalized medicine. With a growing focus on preventive healthcare and health screenings, diagnostic centres offer a wide range of diagnostic tests and services. Moreover, advancements in diagnostic technologies such as molecular diagnostics and point-of-care testing drive market growth. Additionally, the rising prevalence of chronic diseases and aging population further fuel demand for diagnostic services sustaining sales for diagnostic centres.

• Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Academic & Research Institutes
• Forensic Science Laboratories
• Diagnostic Centers
• Others

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion